- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer Center
OncoLink at ASCO 1996: Saturday, May 18
Photo (l to r): Gloria Bosi, MD & Amelia Trenghi, MD, Ravenna, Italy Anna Maria Mulino, Verona, Italy
|
Exclusive Interview with John Glick, MD
Dr. Bunn: There are six new drugs which have been approved or are about to be approved for treating lung cancer and they're probably all six of them better than drugs which we've had in the past, and I think they will improve survival for... |
|
|
Importance of Outcomes Research
The American Society of Clinical Oncology (ASCO) held an interactive discussion of "outcomes research" -- one of the most timely issues in cancer treatment. This roundtable occurred between an expert panel and oncology specialists at the Annual... |
|
|
Interview with Paul A. Bunn, Jr., MD
Dr. Bunn: There are six new drugs which have been approved or are about to be approved for treating lung cancer and they're probably all six of them better than drugs which we've had in the past, and I think they will improve survival for... |
|
|
New Combinations in Lung Cancer
Panelists CHAIR: Paul A. Bunn, Jr., MD University of Colorado Cancer Center Robert Ginsberg, MD Memorial Sloan-Kettering Cancer Center William T. Sause, MD LDS Hospital Photo (l to r): Paul A. Bunn, Jr., MD.; Robert Ginsberg, MD;... |
|
|
Presidential Symposium on Genetic Testing
Would you want to know if you are at an approximately 90% risk of developing breast and/or ovarian cancer at some point in your life, perhaps even before the age of 40? The availabiility of the DNA test for BRCA1 mutations has raised questions... |
|
|
The Internet for Oncologists: Hunting for Genes on the World Wide Web
Panelists CHAIR: Mark Boguski, MD PhD National Center for Biotechnology Information Susan Hubbard, RN National Cancer Institute, International Cancer Information Center L. Michael Glode, MD University of Colorado Sciences Center ... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
